Herranen, Anni
Ikäheimo, Kuu
Lankinen, Tuuli
Pakarinen, Emmi
Fritzsch, Bernd http://orcid.org/0000-0002-4882-8398
Saarma, Mart http://orcid.org/0000-0001-5543-7160
Lindahl, Maria
Pirvola, Ulla http://orcid.org/0000-0001-5285-4225
Funding for this research was provided by:
Instrumentariumin Tiedesäätiö
Magnus Ehrnroothin Säätiö
Genelec Inc, Iisalmi, Finland Finnish Association of Otorhinolaryngology and Head and Neck Surgery, Tampere, Finland
Jenni and Antti Wihuri foundation, Helsinki,Finland
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01 AG060501)
Jane ja Aatos Erkon Säätiö
Academy of Finland (310891, 117044, 117044)
Article History
Received: 13 November 2019
Revised: 16 January 2020
Accepted: 17 January 2020
First Online: 6 February 2020
Conflict of interest
: M.S. and M.L. are inventors in the MANF-related US patent (9592270B2, Neurotrophic factor MANF and uses thereof) that is owned by Herantis Pharma Plc. M.S. is a shareholder in this company.